학술논문

Deferred treatment with sofosbuvir–velpatasvir–voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1
Document Type
Article
Source
In The Lancet Gastroenterology & Hepatology August 2018 3(8):559-565
Subject
Primary Research
Articles
Language
ISSN
2468-1253